Skip to main content

Table 4 Association of senile plaque coverage with APOE, CLU, CR1 and PICALM genotypes

From: CLU, CR1 and PICALM genes associate with Alzheimer's-related senile plaques

   

Sparse SP

Moderate SP

Frequent SP

 

Valid N

No SP

Sparse SP

OR (95% CI)

P-value

Moderate SP

OR (95% CI)

P-value

Frequent SP

OR (95% CI)

P-value

APOEε4-1

378

281 (74.3)

51 (13.5)

-

-

29 (7.7)

-

-

17 (4.5)

-

-

APOEε4+

174

89 (51.1)

39 (22.4)

2.86 (1.73 to 4.74)

<0.0001*

32 (18.4)

5.32 (2.81 to 10.06)

<0.0001*

14 (8.0)

3.97 (1.76 to 8.94)

0.001*

CLU TT2

329

227 (69.0)

48 (14.6)

-

-

33 (10.0)

-

-

21 (6.4)

-

-

CLU C+

192

123 (64.1)

37 (19.3)

1.26 (0.76 to 2.09)

0.378

23 (12.0)

1.06 (0.55 to 2.03)

0.873

9 (4.7)

0.68 (0.29 to 1.63)

0.391

CR1 AA2

182

125 (68.7)

22 (12.1)

-

-

21 (11.5)

-

-

14 (7.7)

-

-

CR1 C+

355

234 (65.9)

65 (18.3)

1.48 (0.85 to 2.58)

0.167

38 (10.7)

0.92 (0.48 to 1.78)

0.807

18 (5.1)

0.62 (0.28 to 1.38)

0.242

PICALM CC2

217

136 (62.7)

33 (15.2)

-

-

32 (14.7)

-

-

16 (7.4)

-

-

PICALM T+

319

222 (69.6)

54 (16.9)

0.97 (0.58 to 1.60)

0.898

27 (8.5)

0.43 (0.23 to 0.82)

0.010*

16 (5.0)

0.58 (0.26 to 1.26)

0.169

  1. Abbreviations: APOE , Apolipoprotein E; CI, confidence intervals; CLU , Clusterin; CR1, complement component (3b/4b) receptor 1; N, number of cases; OR, odds ratio; PICALM, phosphatidylinositol-binding clathrin assembly protein; SP, senile plaques. No SP was the reference group. Numbers in brackets are percentages, unless otherwise stated. In some cases it was impossible to obtain all variables due to technical difficulties and sample damage.
  2. * Denotes statistically significant values.
  3. 1 Denotes reference group used for statistical analyses. Age was used as a covariate.
  4. 2 Denotes most common homozygous genotype and used as the reference group for statistical analyses. APOEε4 carriership and age were used as covariates.